Michael F. Dubin - 26 Jul 2021 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Christopher Chipman, attorney-in-fact
Issuer symbol
VRPX
Transactions as of
26 Jul 2021
Net transactions value
$0
Form type
4
Filing time
05 Aug 2021, 18:11:00 UTC
Next filing
05 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +20,225 $0.000000 20,225 26 Jul 2021 Common Stock, par value $0.00001 per share 20,225 $4.32 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.